Observational Usage Study of Statins in Primary Care in France
NCT00680082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2100
Last updated 2010-12-02
Summary
To describe the way statins are used in France in primary care, that is to determine patients profile (particularly CV risk factors), to determine the way statins are initiated by general practitioners, to evaluate aftercare and to assess patients treated by rosuvastatin
Conditions
- Healthy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Francois Morand · Cegedim Strategic Data - Boulogne Billancourt - France
-
Jean Dallongeville · Institut Pasteur - Inserm U744 - Lille -France
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- China
Study Locations
More Related Trials
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
NCT02532309 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)
NCT02284503 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
NCT03806101 ·Status: COMPLETED ·Phase: PHASE1
-
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
NCT00695539 ·Status: COMPLETED
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
NCT00660764 ·Status: COMPLETED
-
Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
NCT02420899 ·Status: UNKNOWN ·Phase: NA
-
Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement
NCT03521700 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of RO4917838 With Rosuvastatin in Healthy Volunteers
NCT01183585 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
NCT00296400 ·Status: COMPLETED ·Phase: PHASE2
-
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00296387 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
NCT02859480 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin
NCT03007524 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
NCT00837083 ·Status: COMPLETED
-
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia
NCT00240357 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
NCT03339752 ·Status: COMPLETED ·Phase: PHASE1
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3